COVID-19 restrictions to remain in place at The Walton Centre

Restrictions remain in place across the NHS in relation to the COVID-19 pandemic. The safety measures in place over the 18 months therefore remain in place at The Walton Centre - and in our other clinic settings within the community – until further notice.

Due to the increased transmission risk posed by the Omicron variant, visiting has been suspended within The Walton Centre except for exceptional circumstances.

Clinical studies and trials

The Walton Centre currently has over 75 studies open to recruitment at our site. These cover many different neurological and surgical conditions, including Parkinson’s disease, Huntington’s disease, and many neurological disorders.

Please find below a list of larger studies currently taking place at The Walton Centre. Please note that there are many other trials which are not listed on this page that may be suitable for you. For further information in getting involved in clinical research, please see our page on Getting involved in research

TONiC – Trajectories of Outcome in Neurological Conditions

 

TONiC is a national study examining the factors that influence quality of life in patients with neurological conditions. It is one of the largest studies on quality of life in neurological conditions ever performed within the UK. 

It is hoped that TONiC will have a significant and positive impact on the lives of all patients that suffer from neurological diseases regardless of symptoms, stage of illness, age or social status.

Find out more

 

 

ENROLL-HD

Enroll-HD is a worldwide study for Huntington’s disease families. It will monitor how the disease appears and changes over time in different people, and is open to people who either have HD or are at-risk. Knowing how the disease unfolds will make it much easier to determine what drugs and treatments will help to slow down or stop these changes.

Find out more

 

Tessa Jowell BRAIN MATRIX

The BRAIN MATRIX research trial is a first-of-its-kind clinical trial, aiming to collect a comprehensive data set of patients to help provide a better diagnosis of their disease. It aims to improve overall quality of life, as well as refining and improving surgery based on its findings.

Find out more

 

PROGRESS – Atogepant in Chronic Migraine

PROGRESS is one of a number of drug trials taking place at The Walton Centre, studying the effects of a drug called Atogepant on preventing chronic migraine. Approximately 30 people will be recruited into the study within the UK. For further information please contact the team at RDI@thewaltoncentre.nhs.uk 

 

Developing a preconception care pathway for women with epilepsy

This is a national study to develop a preconception care pathway for women with epilepsy in the UK. We hope this study will have an impact to improve the lives of women with epilepsy planning pregnancy.

Find out more

 

Page last updated: 31 December 2021